{"created":"2023-06-19T09:51:45.071314+00:00","id":9027,"links":{},"metadata":{"_buckets":{"deposit":"bc3520cb-0668-404b-bb1a-3b0949b149ab"},"_deposit":{"created_by":18,"id":"9027","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"9027"},"status":"published"},"_oai":{"id":"oai:fukuyama-u.repo.nii.ac.jp:00009027","sets":["502:503:627:801"]},"author_link":["46601","46600","46596","46591","46593","46653","46655","46654","46599","45524","46602"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-12-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"36","bibliographicPageEnd":"51","bibliographicPageStart":"50","bibliographic_titles":[{"bibliographic_title":"福山大学薬学部研究年報"},{"bibliographic_title":"Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University","bibliographic_titleLang":"en"}]}]},"item_10002_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"福山大学薬学部"}]},"item_10002_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN10064550","subitem_source_identifier_type":"NCID"}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0288724X","subitem_source_identifier_type":"ISSN"}]},"item_10002_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"松本, 尚樹"}],"nameIdentifiers":[{"nameIdentifier":"46596","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"今, 重之"}],"nameIdentifiers":[{"nameIdentifier":"45524","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"中鶴, 拓也"}],"nameIdentifiers":[{"nameIdentifier":"46601","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"宮下, 友惠"}],"nameIdentifiers":[{"nameIdentifier":"46653","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"乾, 恭輔"}],"nameIdentifiers":[{"nameIdentifier":"46602","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"齋藤, 浩大"}],"nameIdentifiers":[{"nameIdentifier":"46600","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鍛代, 悠—"}],"nameIdentifiers":[{"nameIdentifier":"46593","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"室本, 竜太"}],"nameIdentifiers":[{"nameIdentifier":"46591","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"柏倉, 淳一"}],"nameIdentifiers":[{"nameIdentifier":"46654","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"上出, 利光"}],"nameIdentifiers":[{"nameIdentifier":"46655","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"松田, 正"}],"nameIdentifiers":[{"nameIdentifier":"46599","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-04-08"}],"displaytype":"detail","filename":"50-51 福山大学薬学部研究年報第36号 (発表論文抄録(2017)).pdf","filesize":[{"value":"696.4 kB"}],"format":"application/pdf","license_note":"Copyright(c)2018 by Fukuyama University","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"50-51 福山大学薬学部研究年報第36号 (発表論文抄録(2017))","url":"https://fukuyama-u.repo.nii.ac.jp/record/9027/files/50-51 福山大学薬学部研究年報第36号 (発表論文抄録(2017)).pdf"},"version_id":"6d3d95b8-6a89-4247-b787-a7fe293ac429"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"新規α 9 インテグリンのリガンドであるXCL1/Lymphotactin は、自己免疫疾患マウスモデルの増悪化に関与する","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"新規α 9 インテグリンのリガンドであるXCL1/Lymphotactin は、自己免疫疾患マウスモデルの増悪化に関与する"},{"subitem_title":"A Novel α9 Integrin Ligand, XCL1/Lymphotactin,Is Involved in the Development of Murine Models of Autoimmune Diseases","subitem_title_language":"en"}]},"item_type_id":"10002","owner":"18","path":["801"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-04-08"},"publish_date":"2021-04-08","publish_status":"0","recid":"9027","relation_version_is_last":true,"title":["新規α 9 インテグリンのリガンドであるXCL1/Lymphotactin は、自己免疫疾患マウスモデルの増悪化に関与する"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-06-19T10:10:15.979070+00:00"}